4
Changes in Ownership
Tyra Biosciences, Inc. Filed Acc 0001209191-21-063017
Options or other derivatives
- Chief Technology Officer acquired 99,554 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Derivatives | |||||||
| Hudkins Robert L. Chief Technology Officer | 2021-11-02 | Grant or award · Stock Option (Right to Buy) | +83,626 | 83,626 | D | ||
| Hudkins Robert L. Chief Technology Officer | 2021-11-02 | Grant or award · Stock Option (Right to Buy) | +7,964 | 7,964 | D | ||
| Hudkins Robert L. Chief Technology Officer | 2021-11-02 | Grant or award · Stock Option (Right to Buy) | +7,964 | 7,964 | D | ||
Loading xslF345X03/doc4.xml…